Clik here to view.
QIAGEN announces worldwide shipments of QIAstat-Dx test kits for SARS-CoV-2
HILDEN, Germany & GERMANTOWN, Maryland QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has shipped its newly developed QIAstat-Dx Respiratory Panel 2019-nCoV test kit to...
View ArticleClik here to view.
Gilead Sciences Initiates Two Phase 3 Studies of Investigational Antiviral...
FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq: GILD) today announced the initiation of two Phase 3 clinical studies to evaluate the safety and efficacy of remdesivir in adults diagnosed with...
View ArticleClik here to view.
Antisense Therapeutics Announces Appointment of US-based Consultant Medical...
MELBOURNE, Australia Antisense Therapeutics Limited (ASX:ANP) is pleased to advise of the appointment of Gil Price M.D. as Consultant Medical Director. Dr. Price is a clinical physician trained in...
View ArticleClik here to view.
Inflazome’s Somalix Demonstrates Positive Safety, Tolerability and...
DUBLIN & CAMBRIDGE, United Kingdom & BRISBANE, Australia Inflazome (inflazome.com), the pioneering inflammasome biotech company developing multiple drugs that stop harmful inflammation,...
View ArticleClik here to view.
武田在TAK-062 (Kuma062)治疗乳糜泻1期研究结果出炉后收购PvP Biologics
日本大阪 (美国商业资讯)–在研药物TAK-062 (Kuma062)治疗控制不良的乳糜泻1期机制验证研究结论出炉后，武田药品工业株式会社(TSE:4502/NYSE:TAK)（“武田”）宣布收购PvP Biologics,...
View ArticleClik here to view.
Harbour BioMed Receives U.S. FDA IND Approval for Phase 2 Clinical Trial and...
CAMBRIDGE, Mass. & ROTTERDAM, Netherlands & SUZHOU, China Harbour BioMed (HBM) today announced U.S. Food and Drug Administration (FDA) approval of its Investigational New Drug (IND)...
View ArticleClik here to view.
NuProbe Announces Licensing Deal with Oxford Nanopore
HOUSTON & SHANGHAI NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, TX, has signed an agreement with Oxford Nanopore Technologies, where Oxford...
View ArticleClik here to view.
Harbour BioMed Announces U.S. FDA Approval of IND for Its Next Generation...
CAMBRIDGE, Mass. & ROTTERDAM, Netherlands & SUZHOU, China Harbour BioMed (HBM) today announced U.S. Food and Drug Administration (FDA) approval of its Investigational New Drug (IND)...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion for Subcutaneous Formulation of...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
View ArticleClik here to view.
BioPharma Services Inc.捐赠其临床资源和科学专业知识，用于冠状病毒COVID-19疫苗研究
多伦多 (美国商业资讯)–BioPharma拥有尖端I期临床基础设施以及科学和医学专家团队，该公司今天决定捐赠其世界卫生组织(WHO)核准的设施，用于冠状病毒COVID-19疫苗的研究和治疗。 国际社会继续演进和发展对大规模健康问题的响应，诸如盖茨基金会这样的组织为传染病治疗的发展做出了贡献。同样，BioPharma管理层希望在疫苗研究中发挥自己的作用，以帮助控制病毒和疾病的日益流行。...
View ArticleClik here to view.
Shionogi Receives Positive CHMP Opinion for FETCROJA® (cefiderocol) for the...
OSAKA, Japan & AMSTERDAM Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President & CEO: Isao Teshirogi, Ph.D.) and its European subsidiary, Shionogi B.V. (hereafter “Shionogi”) today...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion for ALUNBRIG® (brigatinib) as a...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...
View ArticleClik here to view.
Now, Get A Free Knock-out Mouse: The Improved Sperm-freezing Technology...
SEOUL, South Korea Macrogen (KOSDAQ: 038290), the Korean precision medicine biotech company, is hosting a ‘Now, Get A Free Knock-out Mouse!’ event on a first-come, first-served basis. The ‘Now, Get...
View ArticleClik here to view.
BioPharma Services Inc. Donates its Clinical Resources and Scientific...
TORONTO With their state-of-the-art Phase 1 clinical infrastructure and expert team of scientific and medical personnel, BioPharma has today decided to donate its World Health Organization (WHO)...
View ArticleClik here to view.
First Patient Enrolled in AVITA Medical’s Pivotal Study Evaluating RECELL...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in...
View ArticleClik here to view.
Company Profile for Pregna International Ltd.
Pregna is a leading Contraceptive Solutions Organization and has been serving women since 1991. Pregna is spread across the globe in 140 countries partnering with social marketing organizations as...
View ArticleClik here to view.
武田薬品が一部の一般用医薬品およびノンコア資産のアシノへの売却を完了
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:4502/NYSE:TAK）（「武田薬品」）は本日、当社グロース＆エマージング マーケッツ ビジネス ユニット（GEM...
View ArticleClik here to view.
武田完成向Acino出售部分非处方药和非核心资产的交易
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（“武田”）今天宣布已完成其先前宣布的一项交易，即以逾2亿美元的总价值向Acino出售其增长与新兴市场业务部门(GEM...
View ArticleClik here to view.
H.E.L Group Focuses on Growth in China
BOREHAMWOOD, England H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety and scale-up, today announced the appointment of Qing...
View ArticleClik here to view.
武田同意以8.25亿美元向Hypera Pharma出让拉丁美洲部分非处方和非核心资产
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（“武田”）今天宣布，其已达成一项协议，将以8.25亿美元总价值将其位于拉丁美洲的专有部分非核心产品组合出让给在品牌处方、消费者健康和品牌仿制药领域处于领先地位的巴西最大制药公司Hypera S.A. (“Hypera...
View Article